How daily rhythms in brain activity affect drug-taking behaviors
Rhythms in Cholinergic Interneuron Activity Mediate Drug-Taking Behaviors
This study is looking at how our body's natural daily rhythms affect drug use and cravings, focusing on a specific part of the brain that plays a big role in addiction, to help find better ways to support people dealing with substance use issues.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10899074 on NIH RePORTER |
What this research studies
This research investigates the connection between circadian rhythms and substance use disorders (SUDs), focusing on how daily patterns in brain activity influence drug-taking and craving behaviors. The study examines the role of cholinergic interneurons in the nucleus accumbens, a key brain region involved in addiction, and how disruptions in these rhythms may contribute to SUDs. By analyzing the firing patterns of neurons and their impact on dopamine release, the research aims to uncover mechanisms that could lead to improved treatment options for individuals struggling with addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing substance use disorders, particularly those who also have sleep disturbances or irregular daily rhythms.
Not a fit: Patients who do not have substance use disorders or those with stable, healthy circadian rhythms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that align with patients' natural rhythms, potentially improving outcomes for those with substance use disorders.
How similar studies have performed: Previous research has indicated that understanding circadian rhythms can significantly impact treatment approaches for various disorders, suggesting potential success for this novel investigation.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Stowe, Taylor Ashley — University of Pittsburgh at Pittsburgh
- Study coordinator: Stowe, Taylor Ashley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.